Several recent studies have shown CBD to exhibit significant bronchodilatory properties. Scientists believe that CBD can dilate the respiratory airways, lowering resistance, and creating better airflow into the lungs.
The 2500 mg bottle was recently introduced by Royal CBD for people needing higher doses of cannabidiol in their lives. Unlike many other full-spectrum products, this oil has a nice, natural taste spiced up by nutty undertones that provide a smooth flavor.
1. CBD as a Bronchodilator
Excessive exposure to irritants that harm the lungs and airways is the leading cause of COPD. Smoking is the most common type of irritant, so tobacco smokers are exposed to a higher risk of developing COPD.
CBD has been studied for its anti-inflammatory effects and its efficacy as a bronchodilator. Both of these effects indicate that CBD may alleviate some of the symptoms of COPD.
COPD is an acronym for chronic obstructive pulmonary disease. This is a progressive lung disease that makes breathing increasingly difficult for patients over time.
This follows the company’s recent filing of an U.S. patent and brand name trademark applications for RespRX specifically for treating COPD symptoms and similar respiratory conditions.
Preliminary results from a study conducted with primates exhibiting symptoms associated with COPD revealed that treatment with RespRX could induce significant increases in respiration rate and inspiratory air flow rate within just two weeks. “These data demonstrate that (…) [RespRX] may have important clinical uses in patients with lung diseases that restrict inspiratory air flow with minimal adverse side effects,” according to the company’s new website.
The company announced that as it moves toward the goal of federal approval of RespRX, its website will be updated regularly with information about the applications’ status, as well as ongoing RespRX investigations and developments, KALY stated in a press release.
Increasing evidence suggests that non-psychotropic cannabis-derived compounds, such as pharmaceutical grade cannabidiol (CBD), may hold clinically relevant effects that can help those affected by a wide range of illnesses.
Kali-Extracts has launched a dedicated website for its cannabis-based therapy candidate, RespRX, for chronic obstructive pulmonary disease (COPD) and related disorders.